Advertisement

Nephrology

Home Nephrology
Patients with atrial fibrillation who take digoxin may face a nearly 30 percent greater risk of death than patients not taking the drug

ACC: Mortality Risk Up With Digoxin Use in A-Fib

May face a nearly 30 percent greater risk of death than patients not taking the drug
A mobile phone application has been released to identify current drug shortages

FDA Launches First App to Identify Drug Shortages

App IDs shortages, resolved shortages, product discontinuation; can be used to report shortages
Rush University Medical Center's website has started adding the results of patient surveys to individual physician profiles

Rush University Adds Patient Scores to Doctor Profiles

Scores based on 30 or more patient surveys completed in one-year period
Patients prefer physicians who convey a more optimistic message

Research Measures Perceptions of Physician Compassion

Patients perceive higher level of compassion among physicians who provide a more optimistic message
Acetaminophen may not be as safe as previously thought

Acetaminophen Risks May Be Underestimated

Researchers call for a new systematic review of acetaminophen's effectiveness and safety

February 2015 Briefing – Nephrology

Here are what the editors at HealthDay consider to be the most important developments in Nephrology for February 2015. This roundup includes the latest...
Hospital design has little effect on patient satisfaction

Hospital Design Has Little Effect on Patient Satisfaction

Aesthetics aren't as important as care from doctors, nurses, and staff, researchers note

Genitourinary Cancers Symposium, Feb. 26-28

The 2015 Genitourinary Cancers Symposium The American Society of Clinical Oncology's annual Genitourinary Cancers Symposium was held from Feb. 26 to 28 in...
Key steps should be taken to minimize the potential risk of liability resulting from use of telemedicine

AMA: Key Steps for Minimizing Liability Risk in Telemedicine

Include defining minimum requirement necessary for establishing doctor-patient relationship
The combination antibiotic Avycaz (ceftazidime-avibactam) has been approved by the U.S. Food and Drug Administration to treat adults with complicated infections of the intra-abdominal area or urinary tract

FDA Approves New Combination Antibiotic Avycaz

Combination drug sanctioned for abdominal, urinary tract infections